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ABSTRACT 
 
Altered amino acid sequence affects amyloid formation in Aβ(25-35) 
 
Morgan Chateau 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
Research Advisor: Dr. Martin Scholtz 
Department of Molecular and Cellular Medicine 
 
Many neurodegenerative diseases are associated with protein misfolding where the 
protein forms β-sheet rich polymers called amyloid.  Alzheimer’s disease (AD) is an 
amyloid aggregation disease involving the Aβ(1-42) peptide fragment of the Amyloid 
Precursor Protein (APP) in the nervous tissue of the brain.  Within the peptide there are 
regions thought to be more critical for amyloid formation; one of which is Aβ(25-35).  
This sequence has the ability to form amyloid at sufficient peptide concentrations. 
Within this region, residues 33-35 have been found by terminal deletions to be a core 
region (1), the residues necessary for amyloid formation.  Using Cys-scanning 
mutagenesis the estimated core region (31-34) is slightly different.  Previous papers have 
shown, the peptide loses the ability to form amyloid fibrils when the sequence of amino 
acids is changed (2). For this experiment, four different Aβ(25-35) sequences were 
tested, each having the same composition but a different sequence.  FPLC was used in 
conjunction with Thioflavin-T fluorescence to monitor amyloid development.  The 
results showed a definite effect on amyloid formation as compared to wild type.  
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Sequence S-N showed nearly no change in behavior. Sequence S-M appeared to loose 
all amyloid forming ability.  The remaining two sequences were unable to remain in 
solution long enough to be accurately tested.   
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NOMENCLATURE 
 
Th-T Thioflavin-T    
S-C  Carboxyl-terminal partial scramble mutant 
S-N Amino- terminal partial scramble mutant 
S-CN Carboxyl- and amino- biterminal partial scramble mutant 
S-M Middle partial scramble mutant 
Wt Wild type (non-mutated Aβ(25-35)) 
FPLC  Fast performance liquid chromatography 
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CHAPTER I 
INTRODUCTION 
 
AD is a neurodegenerative disease commonly associated with the formation of an 
ordered aggregate or plaque in the intracellular space between cells.  These plaques are 
formed by a specific type of protein aggregate classified as amyloid, a β-sheet rich 
polymeric strand made of many misfolded proteins.  The monomeric building blocks are 
known as prions (proteinaceous infectious particles) (3).  Prions are infectious because 
they have the ability to misfold a properly folded protein into a similar prion, bind to it, 
and then misfold another (4).  This unique ability to spread disease without any genetic 
material has created a new classification of disease, prion diseases.  Fully mature 
amyloids also retain this infectivity.   
 
Misfolded proteins (prions) are exported from the cell in monomer form and then bond 
with each other out side of the cell.  Many fibrils may start to grow after a varying lag 
phase.  After fibrils have started they behave like nucleation points and protofibril 
growth accelerates, much like crystals.  These protofibrils then associate to form chains 
that will eventually grow long enough to be seen under the microscope. 
 
This project further explored the importance of amino acid sequence in  
 
amyloid formation. This project tested the possibility that scrambling a part of the  
_______________ 
This thesis follows the style of Journal of Biological Chemistry. 
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peptide sequence will result in the loss of amyloid forming ability of the peptide.   By 
partially changing the sequence of amino acids, an amyloid core region of the peptide 
was indicated. Four partial scrambles were tested; an amino terminus scramble, a 
carboxyl terminus scramble, a center scramble, and a bi-terminus scramble (See Table1).  
Wild type was also tested with each assay as a positive control and as a basis of 
comparison.  
 
The progress of amyloid formation was monitored by watching changes in monomer 
concentrations in solution over time followed by a Thioflavin-T binding test to ensure 
the decreasing levels of monomer was because of amyloid formation and not from 
amorphous aggregate.  The wild type protein reached a stable equilibrium within hours.  
Modification of the sequence may only have slowed amyloid formation instead of 
preventing it.  Therefore, a long time scale assay was done to ensure loss of amyloid 
formation.  Then a series of assays were done focusing on the first twenty hours of 
amyloid formation. 
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CHAPTER II 
METHODS 
 
Partial scramble mutant synthesis 
The five eleven residue peptides were synthesized using solid-state syntheses on Wang 
resin and purified by fast performance liquid chromatography (FPLC) based on 
hydrophobicity with 15RPC resin (5).  Mass spectroscopy was employed to confirm 
peptide identity.  The resulting lyophilized peptide was dissolved in 88% formic acid to 
maintain a monomeric state and stored at -80°C (6).  
TABLE 1 
Sequence of wild type and partially scrambled mutants tested 
Peptide Sequence 
Wt Aβ(25-35) N’-GSNKGAIIGLM-C’ 
S-N N’-NGSKGAIIGLM-C’ 
S-C N’-GSNKGAIILMG-C’ 
S-NC N’-NGSKGAIILMG-C’ 
S-M N’-GSNIAIKGGLM-C’ 
 
Since amyloid fibrils grow similar to the way crystals form, it was important for all 
starting materials to be monomeric, otherwise, the peptides may have had nucleation 
centers already and each assay would have different kinetics, due to varying nucleation 
numbers. 
 
Assay Methods  
Assays were done in 11X34 mm ultra centrifuge tubes using parafilm to prevent 
evaporation.  Each assay involved diluting a quantity of stock solution in water and 
adjusting the pH to the pI(=6) to increase amyloid formation (7).  The tubes were then 
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incubated in a rotor-spinner at 37°C.  Time points were taken by centrifuging the tubes 
at 70K rpm for 25min, taking a 50µL sample of the supernatant, and resuspending the 
pellet by vortexing before returning tubs to incubator. The much heavier amyloid fibrils 
and protofibrils pelleted, leaving only monomer in the supernatant.   
  
The 50µL samples were placed in a -80°C freezer until they could be analyzed by FPLC 
so as to prevent further amyloid formation.  Each sample remained frozen until 
immediately before injection into the FPLC.  This was to ensure the samples did not 
continue reacting while waiting for analysis as even a small amount of time can affect 
the results greatly.  The absorbance at 220nm was recorded for the monomeric peak.   
 
Thioflavin – T Confirmation Test 
A confirmation Thioflavin-T (Th-T) test was done at the end of each assay to ensure the 
presence of amyloid as opposed to an amorphous aggregate (8,9). Th-T is an amyloid 
specific fluorescent dye thought to associate with the protofibrils, a precursor to mature 
amyloid.  When the dye is bound, it fluoresces at a different wavelength than when it is 
not bound, and thus the enhancement of fluorescence is related to the extent of amyloid 
formation (9). 
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CHAPTER III 
RESULTS 
 
Figure 1 shows the long term assay for the four mutants and the wild type protein (Wt)  
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Figure 1.  168 Hour Assay (Dual Trial) done at 37ºC and pH 6.  Two trials were done at the same time 
at the same pH and temperature.   
 
performed with dual trials, as notated by the 1 or 2 following the mutant abbreviation.  
This assay showed that the peptides achieved their final state by the third time point.  
Amyloid formation or lack of formation was evident in less than 47 hours and the 
mutants remained in one state for the duration of the assay.  Only part of the reaction 
mixture for the final time point of S-M2 was analyzed by FPLC due to an accident, 
which would explain the lower reading.   Also, S-C1 was lost within the first reaction 
hour because the parafilm lid was not attached securely and the mixture evaporated. 
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Figure 2. 72 Hour assay done at 37ºC and pH 6.
 
 
The assay was repeated with more frequent time points to help narrow down when the 
peptides reach equilibrium (Figure 2).  As seen in the graph, all strains of mutants 
achieved their final state within twenty hours.  Mutant S-M showed nearly no decrease 
in monomer state peptide concentrations in solution for the duration of the testing time 
period.  Th-T fluorescence confirmed a lack of amyloid presence.  The wild type protein 
showed a characteristic shape seen in previous articles.  The S-N mutant showed a trend 
nearly identical to Wt, suggesting again the order of amino residues in the 25-27 region 
is not essential for amyloid formation.  Th-T confirmed the presence of amyloid 
formation.  S-CN and S-N showed minimal absorbance immediately after mixing the 
initial reaction solutions and maintained these low levels for duration of the assay.  Th-T 
testing for S-CN and S-N was inconclusive of whether aggregate was amyloid or 
amorphous aggregate.  
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
Neurodegenerative diseases like Alzheimer’s Disease are commonly associated with 
protein aggregates classified as amyloid, a β-sheet rich polymeric strand made of many 
monomeric building blocks.  Prions are infectious because they have the ability to 
misfold a properly folded protein, bind to it, and then misfold another (4).  This project 
further explored the importance of amino acid sequence in amyloid formation. 
Scrambling a part of the peptide sequence can affect the amyloid forming ability of the 
peptide.   
 
The wild type peptide from Aβ(25-35) reached a stable equilibrium within hours.  
Modification of the sequence had three different results: no change in amyloid forming 
ability, loss of amyloid forming ability, and instantaneous precipitation out of solution.  
A 168 hour assay (Figure 1) showed that these results were constant after the initial 
twenty hours of reaction, and remained so for the time period tested.  From Figure 2 the 
S-M mutant lost amyloid forming ability and remained in the monomer state in solution.  
This suggests residues 28-32 are part of the core region, which supports the Cys-
scanning core region as described earlier. The S-N mutant exhibited behavior like the 
wild type peptide.  This supports both of the core regions found by deletions and by Cys-
scanning. 
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One point of interest was S-NC’s and S-C’s dramatic decrease in solubility in water 
when there was a small change in the order of residues’ 33-35.  Changing their order 
doesn’t change the net hydrophobicity or β-strand propensities of the peptide.  These 
mutants were soluble in formic acid in the stock solutions.  A possible explanation is that 
putting the hydrophobic residues closer together created a hydrophobic center which 
pulled the peptide out of solution.  
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